510(k) Report

FDA applicant

Vascular Solutions, Inc.

Minneapolis, MN116 decisions2000–202425 recalls

FDA records 116 decisions for Vascular Solutions, Inc. (Minneapolis, MN) from 2000 to 2024: 115 510(k) clearances and 1 original PMA approval. Most are in product codes DQY (Catheter, Percutaneous) and QSX (Hemostatic Wound Dressing With Thrombin Or…). Since 2016 its 510(k)s took a median of 86 days from receipt to decision, against 113 for FDA’s reviews in the same codes and years. Its devices cite 183 predicates, 103 of them its own earlier devices. 25 recalls are linked to its devices, 9 Class I.

FDA’s records also spell it “Vascular Solutions, LLC”, “Vascular Solutions”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Vascular Solutions, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2024

2007: 142008: 62009: 92010: 52011: 72012: 32014: 52015: 22016: 32017: 102018: 62019: 22020: 32021: 12022: 42023: 12024: 1
2007high 14 (2007) · low 0 (2013)2026

2026 so far, outlined.

Recalls per year

1in 2023

2009: 22010: 12011: 32012: 12013: 12014: 1, 1 Class I2016: 3, 3 Class I2017: 12020: 5, 5 Class I2023: 1
2007high 5 (2020) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Vascular Solutions, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Vascular Solutions, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report